CTLA4 and neoplasm: Approaches have been conceived to block counter-regulatory molecules like cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) or programmed death-1 (PD-1), which are often associated with tumor-infiltrating T cells (TILs) whose functions are silenced or exhausted in the tumor microenvironment [1–6].